Skip Navigation
Skip to contents

대한신장학회

My KSN 메뉴 열기

간행물 검색
Comparison of cardiovascular event predictability between 2009 CKD-EPI equation and new 2021 CKD-EPI equations in Korean chronic kidney disease cohort: From KNOW-CKD study
Ji Hye Kim,Minjung Kang,Eunjeong Kang,Hyunjin Ryu,Yujin Jeong,Jayoun Kim,Yong Chul Kim,Seung Seok Han,Hajeong Lee,Kook-Hwan Oh
2022 ; 2022(1):
논문분류 :
춘계학술대회 초록집
Objectives: 2009 CKD-EPI creatinine (Cr) equation is commonly used for estimated glomerular filtration rate (eGFR). However, it contains race component which is not a biological factor and may cause biased racism. Therefore, 2021 CKD-EPI Cr and creatinine-cystatin C (Cr-Cys) equations omitting race factor were introduced. This study evaluated if new 2021 equations have better predictability for cardiovascular events (CVE) and all-cause mortality compared to 2009 equation in Korean chronic kidney disease (CKD) cohort.  Methods: This study included 2207 CKD patients enrolled in KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease (KNOW-CKD). eGFR was calculated using 2009 Cr (eGFRCr), 2021 Cr and Cr-Cys (eGFRCr-Cys) equations. Receiver operating characteristic (ROC) and net reclassification improvement (NRI) were used to compare predictability of each CKD-EPI equation for CVE and CVE and all-cause mortality combined.  Results: Overall prevalence of CVE and all-cause mortality were 9% and 7%. According to multivariable cox-regression model, CVE and all-cause mortality combined risk was reduced every 10 unit increase of eGFR across all three equations (2009 eGFRCr: HR 0.93, 95% CI[0.89, 0.98], 2021 eGFRCr: HR 0.94, 95% CI[0.89, 0.98], 2021 eGFR Cr-Cys: HR 0.92, 95% CI[0.87, 0.96]). Area under curves of ROC for both CVE (0.715, 0.716, 0.716) and CVE and all-cause mortality combined (0.747, 0.747, 0.751) did not show significant differences among the three equations. Compared to 2009 equation, both 2021 Cr (NRI 0.013, 95% CI[-0.002, 0.028], p=0.09) and Cr-Cys (NRI -0.001, 95% CI[-0.031, 0.029], p=0.94) equations did not show improved CVE predictability. Similar findings were observed for CVE and all-cause mortality combined for both 2021 Cr (NRI -0.019, 95% CI[-0.039, 0], p=0.06) and Cr-Cys (NRI -0.002, 95% CI[-0.023, 0.018], p=0.82).  Conclusions: Neither 2021 CKD-EPI Cr, nor Cr-Cys equations showed significant improvement in predicting CVE and all-cause mortality in Korean CKD patients compared to 2009 CKD-EPI Cr equation. 
위로가기

(06022) 서울시 강남구 압구정로 30길 23 미승빌딩 301호

Copyright© 대한신장학회. All rights reserved.